Assessment of Variation of PKA and Other Molecular Markers in Patients Undergoing Resection of Colon Cancer Metastases
- Determine the effect of surgical resection, in terms of physiological stress, on levels
of tumor markers such as protein kinase A (PKA) expression in patients with metastatic
- Estimate variation among patients of baseline tumor markers in tumor tissue and sera.
- Correlate markers in tumor tissues with that in sera in these patients.
- Establish a tissue bank of these specimens for future studies.
OUTLINE: Biopsy and surgical specimens are obtained before and during standard surgery
(patients may have had tumor tissue obtained before study entry and stored). Serum samples
and tumor tissue are analyzed by immunohistochemistry and western blot. Tumor markers (such
as PKA expression) are determined and marker levels are measured in serum samples and
PROJECTED ACCRUAL: Approximately 30 patients will be accrued for this study.
Observational Model: Case-Only, Time Perspective: Prospective
John L. Marshall, MD
Lombardi Cancer Research Center
United States: Food and Drug Administration
|Lombardi Comprehensive Cancer Center at Georgetown University Medical Center||Washington, District of Columbia 20007|